Tags: Chemical Compound, Chemical Substance.

Asunaprevir (formerly BMS-650032) is an experimental drug candidate for the treatment of hepatitis C. It is undergoing development by Bristol-Myers Squibb and is currently in Phase III clinical trials.Asunaprevir is an inhibitor of the hepatitis C virus enzyme serine protease NS3.Asunaprevir is being tested in combination with pegylated interferon and ribavirin as well as in interferon-free regimens with other direct-acting antiviral agents including daclatasvir

Asunaprevir.svg
IUPAC name
3-Methyl-N-[(2-methyl-2-propanyl)oxy]carbonyl-(L)-valyl-(4R)-4-[(7-chloro-4-methoxy-1-isoquinolinyl)oxy]-N-(1R2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2-vinylcyclopropyl-(L)-prolinamide

Loading...

This page contains content from the copyrighted Wikipedia article "Asunaprevir"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.